Philippines - English - FDA (Food And Drug Administration)

alcon laboratories (phils.), inc. - intraocular irrigating solution - sterile intraocular irrigating solution - 6.4mg + 1.7mg + 3.9mg + 0.75mg + 0.48mg + 0.30mg

Philippines - English - FDA (Food And Drug Administration)

alcon laboratories (phils.), inc. - bss (balanced salt solution) sterile intraocular irrigating solution - intraocular irrigating solution - 0.6% + 0.075% + 0.048% + 0.030%

Philippines - English - FDA (Food And Drug Administration)

alcon laboratories (phils.), inc.; distributor: alcon laboratories (phils.), inc. - bss plus sterile irrigating solution - sterile irrigating solution - none

Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corp - balanced salt solution - sterile intraocular irrigating solution - each 100 ml contains 640 mg sodium chloride; 75 mg potassium chloride; 48 mg calcium chloride, dihydrate; 30 mg magnesium chloride, hexahydrate; 390 mg sodium acetate, trihydrate & 170 mg sodium citrate, dihydrate

Singapore - English - HSA (Health Sciences Authority)

alcon pte ltd - ophthalmology - for use as an intraocular irrigating solution during intraocular surgical procedure involving perfusion of the eye.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37), sodium citrate (unii: 1q73q2julr) (sodium cation - unii:lyr4m0nh37) - for use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium phosphate, dibasic, unspecified form (unii: gr686lba74) (sodium cation - unii:lyr4m0nh37), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37) - sodium chloride 7.44 mg in 1 ml - indications and usage:  bss plus is indicated for use as an intraocular irrigating solution during intraocular surgical procedures involving perfusion of the eye. contraindications:  there are no specific contraindications to the use of bss plus; however, contraindications for the surgical procedure during which bss plus is to be used should be strictly adhered to. geriatric use:  no overall differences in safety or effectiveness have been observed between elderly and younger patients. reconstitution instructions directions: use aseptic technique - remove the blue flip-off seal from the bss plus® part i (480 ml) bottle. remove the blue flip-off seal from the bss plus part ii (20 ml) vial. prepare the stoppers on both parts by using sterile alcohol wipes. - peel open a bss plus vacuum transfer device package (supplied) and remove the sterile transfer spike. note: this device is vented permitting air to enter vial during solution transfer, thereby preventing the creation of a vacuum inside the vial. an air-inlet filter is provided to protect the system. do not remove the air-inlet filter. - remove protector from the white plastic piercing pin. - firmly grasp device from behind the flange and insert the white plastic piercing pin into the upright rubber stopper of the bss plus part ii (20 ml) vial. - remove guard from filter needle. firmly grasp vial in the palm of one hand and with thumb and index finger, hold plastic flange against top of vial. - invert vial and immediately insert filter needle into the outer target of the rubber stopper of the bss plus part i (480 ml) bottle. (see illustration.) - fluid will automatically transfer from the vial into the large vacuum bottle unless filter becomes occluded or loss of vacuum occurs. note: an excess amount of bss plus part ii is provided in each vial. a non-transferred solution residual of approximately 0.3 ml can be expected to remain in the vial. - immediately remove needle from the bss plus part i container and discard it after solution transfer has been completed. - place a sterile safety cap over the rubber stopper of part i if the solution is not going to be used immediately. mix the solution gently until uniform. peel off the right-hand side of part i bottle label (fully reconstituted bss plus solution). record the patient’s name and the date and time of reconstitution. bss plus solution is now ready for use. caution: reconstituted bss plus solution must be used within six hours of mixing. discard any solution which has aged beyond that time. never use the same bottle of bss plus solution on more than one patient. alternative transfer method if preferred, the contents of the bss plus part ii component may be aspirated with an 18-gauge cannula attached to a 20 ml syringe and then transferred into the part i bottle. alcon distributed by: alcon laboratories, inc. fort worth, texas 76134 usa revised: april 2023

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37), sodium citrate (unii: 1q73q2julr) (sodium cation - unii:lyr4m0nh37) - sodium chloride 6.4 mg in 1 ml - for use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37), sodium citrate (unii: 1q73q2julr) (sodium cation - unii:lyr4m0nh37) - sodium chloride 6.4 mg in 1 ml - for use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

United States - English - NLM (National Library of Medicine)

omeros corporation - phenylephrine (unii: 1ws297w6mv) (phenylephrine - unii:1ws297w6mv), ketorolac (unii: yzi5105v0l) (ketorolac - unii:yzi5105v0l) - phenylephrine 10.16 mg in 1 ml - omidria ® is added to an ocular irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain. omidria is contraindicated in patients with a known hypersensitivity to any of its ingredients. risk summary there are no available data on omidria use in pregnant women or animals to inform any drug-associated risks. oral administration of ketorolac to rats during late gestation produced dystocia and increased pup mortality at a dose 740-times the plasma exposure at the recommended human ophthalmic dose (rhod). since human systemic exposure to omidria following a lens replacement procedure is low [ see clinical pharmacology ( 12.3) ], the applicability of animal findings to the risk of omidria in humans during pregnancy is unclear. omidria should be used during pregnancy only if the potential benefit justifies the p